6 Stocks Attracting Top Investors

Recs

27

There's a reason why more than 30,000 investors flock to Omaha each May, and millions more rummage through the Berkshire Hathaway annual reports: Gleaning knowledge from proven investors is one way to find the stocks that will make you rich.

Using Motley Fool CAPS, the Fool's 135,000-plus-member investing community, we can see which stocks are receiving a boost in attention from CAPS All-Star players each week. A sudden increase in bullish interest from top-rated investors could signal that the stock deserves further research.

Here are six stocks receiving more support from CAPS All-Stars over the past month:

Company

Industry

% Change in All-Star Bulls From 5/4 to 6/3

CAPS Rating (out of 5)

CAPS Research

China Green Agriculture (AMEX: CGA)

Agricultural

436%

4 Stars CGA

Vanda Pharmaceuticals, Inc. (Nasdaq: VNDA)

Biotechnology

218%

1 Stars VNDA

Cell Therapeutics, Inc. (Nasdaq: CTIC)

Biotechnology

208%

2 Stars CTIC

Brink's Home Security Holdings (NYSE: CFL)

Security

192%

5 Stars CFL

Delta Petroleum Corp. (Nasdaq: DPTR)

Oil, Gas and Consumable Fuels

138%

3 Stars DPTR

Lexington Realty Trust (NYSE: LXP)

Real Estate Investment Trusts (REITs)

106%

3 Stars LXP

Source: Motley Fool CAPS, as of June 3, 2009.

Come join us on CAPS, absolutely free, to learn more about these and countless other interesting stock ideas. Sign up for free.

“Make Big Money With Options” Motley Fool CFO Ollen Douglass recently made over $100,000 buying options on 7 well known stocks. Now we’re committed to turning his small fortune into a massive one! And we want you to join us! Enter your email address to hear more:

Disclosure is important to us here at The Motley Fool. No individual person selected the stocks in this article, so there is no author to disclose an interest in them. Since this article was automatically generated, it is possible that Motley Fool personnel (and even The Motley Fool itself, through our Million Dollar Portfolio, Motley Fool Pro, and Ready Made Millionaire services), have positions in these stocks. We thought you'd like to know that. You can learn more about The Motley Fool’s disclosure policy here.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On June 03, 2009, at 1:58 PM, PowerTrip2000 wrote:

    Cell (CTIC) and Vanda (VNDA) have tremendous futures not only in their companies but in their stock price. The potential of their drugs is tremendous on the upside. The pipeline for Cell Therapeutics is already in motion as is Vanda's. Good luck to investors.

Add your comment.

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 912805, ~/Articles/ArticleHandler.aspx, 12/3/2009 8:02:54 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

The Must-Read Story on Fool.com
Fool Search: Be GM's Next CEO!

By The Motley Fool

Fool Search: Be GM's Next CEO!

Related Tickers

12/2/2009 4:01 PM
CGA $17.90 Up +1.33 +8.03%
China Green Agricu… CAPS Rating: ****
CFL $33.29 Down -0.38 -1.13%
Brink's Home Secur… CAPS Rating: ****
DPTR $0.88 Down -0.03 -2.76%
Delta Petroleum Co… CAPS Rating: ****
CTIC $1.12 Up +0.03 +2.75%
Cell Therapeutics,… CAPS Rating: ***
VNDA $11.50 Up +0.55 +5.02%
Vanda Pharmaceutic… CAPS Rating: *
LXP $5.11 Up +0.09 +1.79%
Lexington Realty T… CAPS Rating: ****

Community: Investing Wiki

Term Of The Hour

EBITDA: EBITDA is Earnings Before Interest, Taxes, Depreciation, and Amortization.

Want to learn more or edit this definition?
Click here to read more!